Privia Health Group, Inc. (PRVA) stock
PRVANasdaqServices-Health ServicesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 15/3056% above fair value
$23.67−0.37 (-1.54%)
Close on Nov 12, 2026Market cap $3.02BP/E 91.0Yield –
Privia Health ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Privia Health's ebitda for the twelve months ending Sep 30, 2026 was $63.81M, up 71.1% year over year. For fiscal 2025 it was $44.14M, up 82.0% from the year before. The highest annual figure on record is $44.14M in fiscal 2025.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $44.14M | +82.0% |
| FY2024 | Dec 31, 2024 | $24.25M | -10.8% |
| FY2023 | Dec 31, 2023 | $27.18M | – |
| FY2022 | Dec 31, 2022 | -$14.55M | – |
| FY2021 | Dec 31, 2021 | -$214.97M | -889.7% |
| FY2020 | Dec 31, 2020 | $27.22M | +55.7% |
| FY2019 | Dec 31, 2019 | $17.49M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $24.04M | +40.0% |
| Q2 FY2026 | Jun 30, 2026 | $15.13M | +155.6% |
| Q1 FY2026 | Mar 31, 2026 | $10.70M | +50.3% |
| Q4 FY2025 | Dec 31, 2025 | $13.94M | +96.8% |
| Q3 FY2025 | Sep 30, 2025 | $17.17M | +125.6% |
| Q2 FY2025 | Jun 30, 2025 | $5.92M | -14.4% |
| Q1 FY2025 | Mar 31, 2025 | $7.12M | +169.3% |
| Q4 FY2024 | Dec 31, 2024 | $7.08M | +121.8% |
| Q3 FY2024 | Sep 30, 2024 | $7.61M | +4.7% |
| Q2 FY2024 | Jun 30, 2024 | $6.92M | -20.2% |
| Q1 FY2024 | Mar 31, 2024 | $2.64M | -67.2% |
| Q4 FY2023 | Dec 31, 2023 | $3.19M | -5.7% |
| Q3 FY2023 | Sep 30, 2023 | $7.27M | – |
| Q2 FY2023 | Jun 30, 2023 | $8.67M | – |
| Q1 FY2023 | Mar 31, 2023 | $8.05M | – |
| Q4 FY2022 | Dec 31, 2022 | $3.38M | – |
| Q3 FY2022 | Sep 30, 2022 | -$3.42M | – |
| Q2 FY2022 | Jun 30, 2022 | -$4.09M | – |
| Q1 FY2022 | Mar 31, 2022 | -$10.43M | -224.9% |
| Q4 FY2021 | Dec 31, 2021 | -$18.23M | -495.0% |
| Q3 FY2021 | Sep 30, 2021 | -$12.34M | -237.1% |
| Q2 FY2021 | Jun 30, 2021 | -$192.75M | -2945.8% |
| Q1 FY2021 | Mar 31, 2021 | $8.35M | +22.2% |
| Q4 FY2020 | Dec 31, 2020 | $4.62M | – |
| Q3 FY2020 | Sep 30, 2020 | $9.00M | – |
| Q2 FY2020 | Jun 30, 2020 | $6.77M | – |
| Q1 FY2020 | Mar 31, 2020 | $6.83M | – |
See a number that looks wrong?